Skip to main content
Revelle Capital

Transaction Type

Growth Capital via Private Credit

Non-dilutive funding solutions that enable European businesses to scale without surrendering equity. Revenue-based lending, recurring revenue facilities, and structured growth financing tailored to high-growth companies.

300+Lenders
15+Years Experience
100+Clients Served
10+Jurisdictions Covered

What Is Growth Capital via Private Credit?

Growth capital via private credit refers to debt financing provided by non-bank lenders specifically designed to fund the expansion of established, revenue-generating businesses. Unlike traditional venture capital or growth equity, which require founders and existing shareholders to dilute their ownership, private credit growth capital preserves the existing cap table while providing the capital needed to accelerate growth initiatives - whether that means entering new markets, launching new products, scaling sales teams, or funding strategic acquisitions.

The structures used in growth capital lending differ materially from conventional corporate debt. Traditional bank lending relies heavily on historical EBITDA and tangible asset coverage, making it unsuitable for high-growth businesses that are reinvesting heavily and may not yet generate significant free cash flow. Private credit lenders, by contrast, have developed underwriting frameworks that value recurring revenue, net revenue retention, customer lifetime value, and unit economics - the same metrics that equity investors use to value these businesses. This allows them to extend credit based on forward-looking revenue trajectories rather than backward-looking profitability.

The most common structures include recurring revenue facilities (typically sized at 1.5-3.0x ARR for software businesses), revenue-based financing (where repayments flex as a percentage of monthly revenue), and structured term loans with flexible amortisation profiles that accommodate the cash flow dynamics of scaling businesses. Interest may be partially capitalised during the growth phase, with step-ups in cash pay as the business matures and generates free cash flow. Warrants or small equity kickers are sometimes included but represent a fraction of the dilution that a comparable equity round would require.

The European growth capital lending market has expanded rapidly since 2022, driven by founders increasingly seeking alternatives to down-round equity financing and by private credit funds diversifying beyond traditional leveraged buyout lending. Specialist growth lending platforms now operate across London, Amsterdam, Berlin, and Paris, with dedicated teams that understand the nuances of SaaS metrics, marketplace economics, and technology-enabled services businesses. For companies with EUR 5-50M in annual recurring revenue and strong growth trajectories, private credit growth capital has become a genuine alternative to Series B and C equity rounds.

When to Use This Structure

Growth capital via private credit is most effective when a business has demonstrated product-market fit and revenue traction but wants to fund the next phase of growth without the dilution, governance changes, and valuation risk associated with an equity round. The following scenarios represent the strongest use cases.

Scaling a SaaS or subscription business with ARR above EUR 5M and net revenue retention above 110% - where recurring revenue provides a predictable base for debt service and the business model supports leverage against future contracted revenue
Funding international expansion into new European markets where the capital requirement is known and time-bound, making debt more efficient than permanent equity capital that will sit on the balance sheet after the expansion is complete
Bridging to profitability for businesses that are approaching breakeven but need 12-18 months of additional runway - avoiding an equity round at a potentially unfavourable valuation when the company is close to self-sustaining cash flow
Financing a specific growth initiative such as a product launch, technology platform migration, or go-to-market buildout where the investment has a defined timeline and expected return that can service the debt
Complementing a smaller equity round to reduce total dilution - using debt to fund the capital-efficient portion of the growth plan while equity covers the higher-risk, longer-duration investments
Funding working capital requirements for rapidly growing businesses where revenue is scaling faster than operating cash flow, creating a temporary funding gap that debt can bridge without permanent equity dilution
Providing acquisition capital for tuck-in acquisitions that immediately contribute revenue and margin, where the target is accretive from day one and the combined entity can service the acquisition debt
Extending runway between equity rounds to hit valuation milestones - using growth debt to fund 6-12 months of additional growth before raising the next equity round at a materially higher valuation

How It Works

The growth capital process through private credit is designed to accommodate the pace at which high-growth businesses operate. From initial engagement to funding, the typical timeline is 4-8 weeks, though repeat borrowers with established lender relationships can move faster. The process prioritises understanding the business model and growth trajectory rather than traditional credit analysis.

1

Business Assessment and Lender Matching

The process begins with a detailed assessment of the business, including ARR or revenue trajectory, unit economics, customer metrics (churn, retention, LTV:CAC), and the specific growth plan that the capital will fund. Revelle Capital prepares a tailored information package and identifies 4-8 growth lending platforms whose mandates, sector expertise, and ticket sizes align with the opportunity. Growth lending is a specialist market - generalist direct lenders rarely have the frameworks to underwrite pre-profit or high-reinvestment businesses, so targeting the right lenders is critical to execution.

2

Term Sheet Negotiation

Selected lenders review the business data and submit indicative terms within 1-2 weeks. Key negotiation points include facility size relative to ARR or revenue, interest rate structure (fixed vs floating, cash pay vs PIK), amortisation profile and prepayment flexibility, financial covenants (typically minimum revenue or ARR thresholds rather than traditional leverage covenants), and any equity participation (warrants, success fees, or equity kickers). We benchmark proposals across lenders and negotiate to optimise the overall cost of capital including the dilutive impact of any equity components.

3

Due Diligence and Credit Approval

The preferred lender conducts due diligence focused on the metrics that drive their credit decision: revenue quality and predictability, customer concentration, cohort analysis, net revenue retention, gross margin trajectory, and the credibility of the growth plan. This is a fundamentally different diligence process from traditional leveraged lending - the lender is underwriting future revenue performance, not historical cash flow coverage. Data room access, management meetings, and customer reference calls are standard. Credit committee approval follows within 1-2 weeks of completing diligence.

4

Documentation and Funding

Legal documentation for growth capital facilities tends to be lighter than traditional acquisition financing, reflecting the different risk profile and covenant structure. Facilities agreements are typically 80-120 pages versus 200+ for leveraged buyout documentation. Security packages vary - some growth lenders take a debenture over all assets, while others rely primarily on IP and contractual rights. Conditions precedent are streamlined. Funding occurs within 1-2 weeks of documentation completion, with the capital typically drawn in a single tranche or in scheduled tranches tied to specific growth milestones.

Typical Terms

Growth capital terms through private credit vary significantly based on the business profile, revenue quality, and growth trajectory. The ranges below reflect current European market conditions for businesses with EUR 5-50M ARR or equivalent revenue.

Facility Size
EUR 5-50M
Typically sized at 1.5-3.0x ARR for SaaS businesses; 0.5-1.5x revenue for non-recurring models
Interest Rate
10-15% total cost
Blended across cash pay (6-10%) and PIK (2-5%); some structures use fixed rates rather than floating
Tenor
3-5 years
Shorter than traditional leveraged lending; reflects the expectation that growth businesses will refinance, raise equity, or achieve exit within this period
Amortisation
Interest-only for 12-24 months, then scheduled amortisation
IO period allows the business to deploy capital before debt service begins; amortisation typically 1-3% per quarter
Prepayment
Flexible with 1-2% premium in Year 1
Growth lenders expect early repayment and structure accordingly; par prepayment after Year 2 is common
Equity Participation
0.5-2.0% warrant coverage
Not always required; more common for higher-risk profiles or where the lender is providing covenant-lite terms
Financial Covenants
Minimum ARR or revenue threshold; minimum cash balance
Revenue-based covenants rather than traditional leverage tests; typically set at 70-80% of plan
Arrangement Fee
1.0-2.0% of facility
Payable at drawdown; lower than acquisition financing due to smaller facility sizes and simpler structures
Security
All-asset debenture, IP assignment, share pledge
Lenders prioritise IP and customer contracts; real estate security rarely relevant for growth businesses
Reporting Requirements
Monthly management accounts, quarterly board packs
More frequent than traditional lending; lenders want visibility on ARR, churn, and pipeline metrics

Structuring a Transaction?

We advise borrowers on private credit structures across European markets. Share your deal parameters and we will map the lender landscape.

Get Structuring Advice

Private Credit vs Bank Lending

Traditional bank lending is largely unavailable for high-growth businesses that prioritise revenue growth over near-term profitability. The comparison below illustrates why private credit has become the dominant source of growth capital debt for scaling European businesses.

Private CreditvsBank Lending
Underwriting Approach
Private CreditForward-looking revenue and ARR-based underwriting. Values recurring revenue, net retention, and unit economics. Comfortable lending to pre-profit businesses with strong growth trajectories.
Bank LendingHistorical EBITDA and asset-based underwriting. Requires 2-3 years of profitable trading. Unable to lend against recurring revenue or future growth potential.
Facility Sizing
Private Credit1.5-3.0x ARR for SaaS; 0.5-1.5x revenue for other models. Sizing reflects revenue quality and growth trajectory, not backward-looking cash flow multiples.
Bank Lending2.0-3.0x historical EBITDA. For a pre-profit growth company, this yields zero lending capacity regardless of revenue quality or growth rate.
Covenant Structure
Private CreditRevenue-based covenants (minimum ARR, minimum cash balance) that align with how growth businesses are managed. Covenants grow with the business rather than constraining it.
Bank LendingTraditional leverage and interest cover covenants that penalise businesses reinvesting for growth. High-growth companies would breach standard bank covenants within quarters of drawdown.
Speed and Process
Private Credit4-8 weeks from engagement to funding. Specialist growth lending teams understand the metrics and can move quickly. Management time commitment is manageable.
Bank Lending8-16 weeks where available. Generalist bank credit teams require extensive education on the business model. Multiple escalation points and committee layers slow the process.
Structural Flexibility
Private CreditPIK interest during growth phase, milestone-based drawdowns, flexible prepayment. Structures designed to accommodate the cash flow profile of scaling businesses.
Bank LendingStandard cash pay interest from day one, fixed amortisation schedules, rigid prepayment penalties. Structures designed for stable, profitable businesses, not growth companies.
Sector Understanding
Private CreditDedicated growth lending teams with backgrounds in technology, venture capital, and growth equity. Understand SaaS metrics, marketplace dynamics, and platform economics.
Bank LendingGeneralist SME lending teams. Limited understanding of recurring revenue models, cohort analysis, or the distinction between high-quality and low-quality growth.
Cost of Capital
Private Credit10-15% blended cost including any warrant coverage. Higher than bank debt but significantly cheaper than equity, which would cost 20-30%+ in dilution for a comparable quantum of capital.
Bank LendingWhere available, 5-8% all-in cost. But availability is the constraint - banks rarely lend to the growth company profile, making the comparison theoretical for most borrowers.

Who Provides Growth Capital Through Private Credit?

The European growth lending market is served by a distinct set of lenders that differ materially from the direct lending funds that dominate acquisition financing. Understanding these categories helps founders and management teams identify the right capital partner for their stage and profile.

Specialist Growth Lending Platforms - A growing number of dedicated growth lending funds operate across Europe, typically founded by teams with backgrounds spanning venture debt, growth equity, and technology investment banking. These platforms focus exclusively on lending to high-growth, technology-enabled businesses and have developed proprietary underwriting frameworks built around SaaS metrics, marketplace KPIs, and recurring revenue analysis. They typically deploy EUR 5-30M per transaction and maintain portfolios of 20-40 companies.

Venture Debt Funds - Several established venture debt providers have expanded their mandates to include later-stage growth capital alongside their traditional early-stage lending. These funds bring deep networks within the venture ecosystem and often co-invest alongside equity rounds. They typically require that the borrower has raised institutional equity capital, using the venture backing as a proxy for business quality. Ticket sizes range from EUR 3-20M.

Technology-Focused Direct Lenders - Some of the larger European direct lending platforms have established dedicated technology and growth verticals within their broader credit strategies. These teams apply the same institutional rigour as the main fund but with underwriting criteria adapted for growth companies. Their advantage is scale - they can deploy EUR 20-75M in a single transaction, making them suitable for larger growth capital needs that specialist platforms cannot fill alone.

Revenue-Based Financing Platforms - A newer category of lender provides capital that is repaid as a fixed percentage of monthly revenue, creating a structure where repayments automatically flex with business performance. These platforms typically serve businesses at an earlier stage (EUR 2-10M revenue) and deploy smaller tickets (EUR 1-5M). The underwriting is heavily data-driven, often integrating directly with the borrower's accounting, banking, and CRM systems.

Insurance and Pension Capital - Several European insurance companies and pension funds have allocated capital to growth lending strategies, either through managed accounts with specialist growth lending managers or through dedicated internal teams. Insurance-backed capital tends to favour lower-risk growth profiles - businesses with strong unit economics, clear paths to profitability, and revenue above EUR 20M - but can offer more competitive pricing due to the lower return hurdle of insurance portfolios.

Deal Reference: European SaaS Growth Capital Facility

Anonymised reference based on comparable transactions seen on the market.

SectorEnterprise Software (SaaS)
Deal SizeEUR 25M recurring revenue facility
Leverage2.0x ARR; not meaningful on an EBITDA basis as the company was reinvesting heavily with trailing EBITDA of EUR 1.2M. On a cash-adjusted basis, the facility represented approximately 1.6x net ARR.
Tenor4 years with interest-only for the first 18 months, followed by quarterly amortisation of 2.5% of the outstanding balance. Voluntary prepayment at 101 in Year 1, par thereafter.
StructureSenior secured term loan sized at 2.0x trailing ARR of EUR 12.5M. Interest structured as 8% cash pay plus 3% PIK during the first 18 months, stepping up to fully cash pay at 11% thereafter. Warrant coverage of 0.75% of fully diluted equity with a 10-year exercise period. All-asset debenture with specific assignment of IP and key customer contracts. Financial covenants include minimum ARR of EUR 10M (80% of trailing) and minimum cash balance of EUR 3M.
OutcomeThe company used the growth capital to expand its sales team across three new European markets and fund a product-led growth initiative. ARR grew from EUR 12.5M to EUR 28M over 24 months, with net revenue retention improving from 115% to 125%. The facility was repaid in full after 30 months from the proceeds of a Series C equity round at a valuation 3.5x higher than the valuation at the time of the debt raise. Total cost of the growth debt was approximately EUR 5.5M in interest and fees plus 0.75% dilution - compared to the 15-20% dilution that an equivalent equity round would have required at the original valuation.

Tell Us About Your Transaction

Share your deal parameters and our team will map the lender landscape. Confidential, no-obligation.

1
Deal Overview
2
Company Profile
3
Contact Details
Confidential
24 Hour Response
No Obligation

Related Private Credit Pages

Explore more private credit topics

Sector

Private Credit for Software and Technology

How private credit lenders evaluate and structure financing for software and technology businesses, including ARR-based lending frameworks.

Country

Private Credit in the United Kingdom

Overview of the UK private credit market, including the growing ecosystem of growth lending platforms based in London.

Transaction

Acquisition Financing

How private credit funds structure acquisition financing for mid-market M&A, including bolt-on facilities for buy-and-build strategies.

Comparison

Private Credit vs Bank Lending

Comparison of private credit and bank lending across execution, pricing, and structural flexibility for European borrowers.

Overview

Private Credit Solutions

Explore the full range of private credit solutions across sectors, geographies, and transaction types available through Revelle Capital.

Frequently Asked Questions

Common questions about this transaction structure

Growth capital via private credit is non-dilutive debt financing provided by specialist lenders to fund the expansion of revenue-generating businesses. Unlike equity financing, it preserves existing ownership while providing capital for scaling. Unlike traditional bank debt, it is underwritten against recurring revenue, ARR, and growth metrics rather than historical EBITDA and tangible assets. Typical structures include recurring revenue facilities sized at 1.5-3.0x ARR, revenue-based financing with repayments that flex with monthly revenue, and structured term loans with flexible amortisation profiles.
Facility sizes typically range from EUR 5-50M for European growth businesses. For SaaS companies, lenders will size facilities at 1.5-3.0x trailing annual recurring revenue, with higher multiples available for businesses demonstrating strong net revenue retention (above 120%) and low gross churn. For non-SaaS businesses with recurring or repeatable revenue, sizing is typically 0.5-1.5x annual revenue. The key determinant is revenue quality and predictability - lenders need confidence that the revenue base will support debt service even if growth slows.
Growth capital via private credit is substantially non-dilutive but not always zero-dilution. Most facilities involve no equity component at all - the lender earns its return entirely through interest and fees. However, some lenders request warrant coverage of 0.5-2.0% of fully diluted equity, particularly for higher-risk profiles or where the business is pre-profit. Even where warrants are included, the total dilution is a fraction of what a comparable equity round would require. A EUR 20M growth debt facility with 1% warrant coverage preserves materially more ownership than raising EUR 20M of equity at a typical growth-stage valuation.
Growth capital lenders evaluate a different set of metrics from traditional debt providers. The core metrics include annual recurring revenue and its growth rate, net revenue retention (the percentage of revenue retained from existing customers including upsell), gross margin and contribution margin, customer acquisition cost relative to lifetime value (LTV:CAC), gross and logo churn rates, and cash burn rate relative to revenue growth. Lenders want to see that each unit of revenue is economically attractive and that the business is scaling efficiently. A company growing at 80% with 130% NRR and a 3-year CAC payback period is a very different credit proposition from one growing at 80% with 90% NRR and a 5-year payback.
Growth capital via private credit and equity financing serve complementary but distinct purposes. Equity is permanent capital with no repayment obligation, making it suitable for longer-duration, higher-risk investments where the outcome is uncertain. Growth debt is term capital with a defined cost, making it optimal for investments with predictable returns and defined timelines - international expansion, sales team scaling, or product launches where the business case is well understood. The cost difference is substantial: growth debt typically costs 10-15% annually plus any warrant dilution, while equity at a growth stage effectively costs 25-35%+ annually when measured by the dilution relative to expected value creation. Many companies use both - raising a smaller equity round for the highest-risk investments while using growth debt for the capital-efficient components of their plan.
Yes, pre-profit companies are a core market for growth capital lending, provided they meet certain criteria. Lenders need to see meaningful revenue (typically EUR 5M+ ARR or equivalent), strong unit economics indicating a credible path to profitability, manageable cash burn relative to the facility size, and sufficient runway to service the debt. The key distinction is between businesses that are pre-profit by choice (reinvesting heavily to capture a large market opportunity) and those that are pre-profit because the business model does not generate attractive margins. The former is highly financeable through growth debt; the latter is not.
Growth capital facilities include financial covenants designed to flag underperformance early - typically minimum ARR or revenue thresholds set at 70-80% of plan, and minimum cash balance requirements. If the business misses these thresholds, the lender has the right to engage in a dialogue about remediation but rarely accelerates the facility immediately. Most growth lenders prefer to work constructively with management to develop a recovery plan, which may involve adjusting the growth strategy, reducing burn, or bringing in additional equity capital. The lender's priority is recovery of principal, which is best achieved through a performing business rather than enforcement. That said, persistent underperformance will eventually lead to more protective measures, including cash sweeps, additional reporting requirements, or in extreme cases, restructuring of the facility.

Let Us Find the Right Private Credit Solution

With access to 300+ lenders across Europe, we match borrowers with the capital structures that fit. Confidential, no-obligation initial conversation.